Research Article
K M Argraves, K F Kozarsky, J T Fallon, P C Harpel, D K Strickland
Title and authors | Publication | Year |
---|---|---|
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the role of the LDL receptor
FJ Raal, RP Giugliano, MS Sabatine, MJ Koren, D Blom, NG Seidah, N Honarpour, A Lira, A Xue, P Chirovolu, S Jackson, M Di, M Peach, R Somaratne, SM Wasserman, R Scott, EA Stein |
Journal of lipid research | 2016 |
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon
M Bucci, C Tana, MA Giamberardino, F Cipollone |
Nutrition, Metabolism and Cardiovascular Diseases | 2016 |
Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease
MB Boffa |
Current Atherosclerosis Reports | 2016 |
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)
X Yang, A Sethi, LR Yanek, C Knapper, BG Nordestgaard, A Tybjærg-Hansen, DM Becker, RA Mathias, AT Remaley, LC Becker |
Circulation. Cardiovascular genetics | 2016 |